Skip to main content

Elicio Therapeutics, Inc.

ELTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001601485

No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Elicio Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Elicio Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Elicio Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Adams JulianDirector–Sep 2, 20261
Ashe Carol GailDirector–Sep 2, 20261
Chudnovsky YekaterinaDirector, 10% Owner5,416,212IndirectSep 2, 20261
Nissenson AllenDirector9,383Sep 2, 20261
Ruffolo Robert RDirector–Sep 2, 20261
Wilson Karen JDirector–Sep 2, 20261
Venkatesan JayDirector179,581Sep 2, 20261
Haqq ChristopherSee Remarks57,381Jul 17, 20262
DeMuth PeterChief Scientific Officer21,543Jul 17, 20263
Shah PreetamSee Remarks24,000Jul 17, 20262
Connelly RobertCEO, President and Director120,570Jul 17, 20262
GKCC, LLC10% Owner5,416,212IndirectJun 4, 20250
Piekos BrianChief Financial Officer–Feb 5, 20240
Goldberg ItzhakDirector1,687,986Jul 11, 20220
Omenn Gilbert SDirector–Jun 13, 20220
Ganzi Victor FDirector823,117Jun 13, 20220
Curhan Gregory SSee Remarks4,000Mar 4, 20220
Rhodes Jennifer JSee Remarks30,399Mar 4, 20220
Neylan John F.See Remarks35,136Mar 4, 20220
Eisa-Abc LLC10% Owner2,740,978Aug 31, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 2, 2025 (view filing)Jun 28, 2024188 daysVenkatesan JayDirectorPPurchase+100.0K$2.50+$249.5K–50.0K afterAmendedDerivative2 lots
Aug 14, 2024 (view filing)4:41 PM ETAug 122 daysChudnovsky Yekaterina and 1 otherDirector, 10% OwnerPPurchase+3.44M$5.81+$20.0M–3.44M afterDerivative
Jul 2, 2024 (view filing)4:30 PM ETJun 284 daysChudnovsky Yekaterina and 1 otherDirector, 10% OwnerPPurchase+3.20M$2.50+$7.98M–1.60M afterDerivative2 lots
Mar 20, 2024 (view filing)4:28 PM ETMar 191 dayChudnovsky Yekaterina and 1 otherDirector, 10% OwnerPPurchase+1.03M$5.81+$6.00M–1.03M afterDerivative
Dec 26, 2023 (view filing)4:29 PM ETDec 224 daysChudnovsky Yekaterina and 1 otherDirector, 10% OwnerPPurchase+1.21M$5.81+$7.05M+172.6%1.92M after
May 27, 2022 (view filing)Feb 9, 2021472 daysVenkatesan JaySee RemarksSSale−159.2K$16.00−$2.55M−10.4%1.37M afterAmended
May 27, 2022 (view filing)Feb 9, 2021472 daysGanzi Victor FDirectorSSale−246.7K$16.00−$3.95M−23.1%823.1K afterAmended
May 27, 2022 (view filing)May 252 daysVenkatesan JaySee RemarksPPurchase+11.3K$1.25+$14.1K+0.6%1.89M after
May 25, 2022 (view filing)May 20-245 daysLateVenkatesan JaySee RemarksPPurchase+82.2K$1.23+$101.4K+5.0%1.72M after2 lots
May 23, 2022 (view filing)May 19-204 daysNissenson AllenDirectorPPurchase+9.38K$1.16+$10.9KNew position9.38K after2 lots
Dec 29, 2021 (view filing)Dec 27-282 daysVenkatesan JaySee RemarksPPurchase+277.2K$2.63+$730.1K+20.4%1.64M after2 lots
Dec 22, 2021 (view filing)Dec 202 daysVenkatesan JaySee RemarksPPurchase+3.53K$2.54+$8.96K+0.3%1.36M after
Dec 21, 2021 (view filing)Dec 201 dayNeylan John F.See RemarksSSale−358$2.62−$937.96−1.0%35.1K after
Dec 20, 2021 (view filing)Dec 16-174 daysVenkatesan JaySee RemarksPPurchase+41.6K$2.55+$106.0K+3.2%1.36M after2 lots
Dec 17, 2021 (view filing)Dec 152 daysVenkatesan JaySee RemarksPPurchase+77.6K$2.41+$187.0K+6.3%1.32M after
Dec 16, 2021 (view filing)Dec 151 dayCurhan Gregory SSee RemarksPPurchase+4.00K$2.37+$9.48KNew position4.00K after
Dec 15, 2021 (view filing)Dec 141 dayRhodes Jennifer JSee RemarksSSale−451$2.42−$1.09K−1.5%30.4K after
Dec 7, 2021 (view filing)Dec 61 dayGoldberg ItzhakSee RemarksSSale−32.1K$3.35−$107.6K−1.8%1.72M after
Dec 3, 2021 (view filing)Dec 1-32 daysGoldberg ItzhakSee RemarksSSale−117.9K$3.48−$410.1K−6.3%1.75M after3 lots
Nov 22, 2021 (view filing)Nov 184 daysNeylan John F.See RemarksSSale−374$4.13−$1.54K−1.0%35.5K after
Nov 17, 2021 (view filing)Nov 15-162 daysGoldberg ItzhakSee RemarksSSale−150.0K$4.19−$629.0K−7.4%1.87M after2 lots
Nov 16, 2021 (view filing)Nov 151 dayRhodes Jennifer JSee RemarksSSale−433$4.40−$1.91K−1.4%30.9K after
Oct 20, 2021 (view filing)Oct 182 daysNeylan John F.See RemarksSSale−373$8.62−$3.22K−1.0%35.9K after
Oct 15, 2021 (view filing)Oct 141 dayRhodes Jennifer JSee RemarksSSale−430$8.65−$3.72K−1.4%31.3K after
Sep 21, 2021 (view filing)Sep 201 dayNeylan John F.See RemarksSSale−376$10.07−$3.79K−1.0%36.2K after
Sep 15, 2021 (view filing)Sep 141 dayRhodes Jennifer JSee RemarksSSale−430$10.64−$4.58K−1.3%31.7K after
Aug 19, 2021 (view filing)Aug 181 dayNeylan John F.See RemarksSSale−381$9.03−$3.44K−1.0%36.6K after
Aug 17, 2021 (view filing)Aug 161 dayRhodes Jennifer JSee RemarksSSale−445$10.68−$4.75K−1.4%32.1K after
Jul 22, 2021 (view filing)Jul 211 dayRhodes Jennifer JSee RemarksSSale−432$10.94−$4.73K−1.3%32.6K after
Jul 22, 2021 (view filing)Jul 211 dayNeylan John F.See RemarksSSale−365$10.98−$4.01K−1.0%37.0K after